Humacyte, Inc.

Rachunek Zysków i Strat





Przychody TTM (mln): 11
EBIT TTM (mln): -140
index 0 1 2 3 4 5
Rok finansowy 2019 2020 2021 2022 2023 2024
Przychód (mln) 6 1 1 2 0 0
Przychód Δ r/r 0.0% -75.9% -15.3% 23.9% -100.0% 0.0%
Marża brutto -1122.0% -465.5% 96.1% -427.5% -inf% 0.0%
EBIT (mln) -86 -65 -81 -85 -100 -114
EBIT Δ r/r 0.0% -24.6% 25.7% 4.1% 18.3% 14.3%
EBIT (%) -1385.0% -4332.7% -6429.8% -5404.3% 0.0% nan
Koszty finansowe (mln) 2 2 4 6 -7 -9
EBITDA (mln) -79 -56 -137 -160 -92 -114
EBITDA(%) -1275.9% -3753.9% -10845.6% -10245.7% 0.0% nan
Podatek (mln) 0 2 -64 -76 0 0
Zysk Netto (mln) -85 -69 38 64 -111 0
Zysk netto Δ r/r 0.0% -19.5% -154.6% 71.1% -272.5% -100.0%
Zysk netto (%) -1380.7% -4609.4% 2972.0% 4103.5% 0.0% 0.0%
EPS -4.25 -11.8 0.94 0.62 -1.07 -1.26
EPS (rozwodnione) -4.25 -11.8 0.94 0.62 -1.07 -1.26
Ilośc akcji (mln) 20 6 40 103 103 118,479
Ważona ilośc akcji (mln) 20 6 40 103 103 118,479
Waluta USD USD USD USD USD USD